Halozyme Therapeutics Inc. will release its fourth quarter and full year 2025 financial and operating results on Tuesday, February 17, 2026, following the close of trading. The results will be available through the "Investors" section of Halozyme's corporate website at https://www.halozyme.com. A conference call to discuss the results will be held on Tuesday, February 17, 2026, at 1:30pm PT/4:30pm ET. The call can be accessed live with pre-registration via this link and a live webcast and replay will also be available through the "Investors" section of the company website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA85122) on February 10, 2026, and is solely responsible for the information contained therein.